Literature DB >> 2474676

Use of TrpE/Gag fusion proteins to characterize immunoreactive domains on the human immunodeficiency virus type 1 core protein.

M G Windheuser1, G E Tegtmeier, C Wood.   

Abstract

The human immunodeficiency virus (HIV) p24 core protein is one of the most immunogenic of HIV structural proteins. Infected individuals develop high titers of antibodies against p24 early in infection, which makes anti-p24 antibodies important serological markers. However, despite the clinical importance of the anti-p24 response, no systematic study to characterize the antigenic domains on the p24 protein has been reported. We report here on the use of 12 overlapping fragments of the HIV type 1 p24 protein, synthesized in bacteria as TrpE/Gag fusion proteins, to identify at least two and possibly three antigenic domains on the p24 protein. In addition, we note that different HIV-seropositive sera exhibited different patterns of reactivity with the p24 domains presented on our fusion proteins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2474676      PMCID: PMC251008     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Complete nucleotide sequence of the AIDS virus, HTLV-III.

Authors:  L Ratner; W Haseltine; R Patarca; K J Livak; B Starcich; S F Josephs; E R Doran; J A Rafalski; E A Whitehorn; K Baumeister
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

2.  Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2).

Authors:  R Sanchez-Pescador; M D Power; P J Barr; K S Steimer; M M Stempien; S L Brown-Shimer; W W Gee; A Renard; A Randolph; J A Levy
Journal:  Science       Date:  1985-02-01       Impact factor: 47.728

3.  Viral envelope protein of HTLV-III is the major target antigen for antibodies in hemophiliac patients.

Authors:  L Kitchen; G Malone; S Orgad; F Barin; R Zaizov; B Ramot; E Gazit; J Kreiss; M Leal; I Wichmann
Journal:  J Infect Dis       Date:  1986-04       Impact factor: 5.226

4.  Using mini-prep plasmid DNA for sequencing double stranded templates with Sequenase.

Authors:  R Kraft; J Tardiff; K S Krauter; L A Leinwand
Journal:  Biotechniques       Date:  1988-06       Impact factor: 1.993

5.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

6.  Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients.

Authors:  W G Robey; B Safai; S Oroszlan; L O Arthur; M A Gonda; R C Gallo; P J Fischinger
Journal:  Science       Date:  1985-05-03       Impact factor: 47.728

7.  Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS.

Authors:  J Schüpbach; O Haller; M Vogt; R Lüthy; H Joller; O Oelz; M Popovic; M G Sarngadharan; R C Gallo
Journal:  N Engl J Med       Date:  1985-01-31       Impact factor: 91.245

8.  Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24.

Authors:  J M Casey; Y Kim; P R Andersen; K F Watson; J L Fox; S G Devare
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

9.  Analysis of adenovirus transforming proteins from early regions 1A and 1B with antisera to inducible fusion antigens produced in Escherichia coli.

Authors:  K R Spindler; D S Rosser; A J Berk
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

10.  Variation in human T lymphotropic virus III (HTLV-III) antibodies in homosexual men: decline before onset of illness related to acquired immune deficiency syndrome (AIDS).

Authors:  R J Biggar; M Melbye; P Ebbesen; S Alexander; J O Nielsen; P Sarin; V Faber
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-12
View more
  3 in total

1.  Characterization of the antigenic domains of the major core protein (p26) of equine infectious anemia virus.

Authors:  Y H Chong; S L Payne; C J Issel; R C Montelaro; K E Rushlow
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

2.  Identification and mapping of the gene encoding the glycoprotein complex gp82-gp105 of human herpesvirus 6 and mapping of the neutralizing epitope recognized by monoclonal antibodies.

Authors:  B Pfeiffer; Z N Berneman; F Neipel; C K Chang; S Tirwatnapong; B Chandran
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

Review 3.  Mapping of viral epitopes with prokaryotic expression products.

Authors:  J A Lenstra; J G Kusters; B A van der Zeijst
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.